Table of Contents

company-logo

Olymvax Biopharmaceuticals Inc. develops and supplies vaccines. The company offers vaccines for Tetanus, a deadly infectious disease that causes nervous system toxicity by toxigenic clostridium tetanus; and haemophilus influenzae type b. it also develops vaccines for Staphylococcus aureus, a pathogenic bacterium that causes hospital infection and community infection; and Group A streptococcus disease. The company was founded in 2009 and is based in Chengdu, China.

Chengdu Olymvax Biopharmaceuticals Dividend Announcement

• Chengdu Olymvax Biopharmaceuticals announced a annually dividend of ¥0.04 per ordinary share which will be made payable on 2024-06-25. Ex dividend date: 2024-06-25
• Chengdu Olymvax Biopharmaceuticals annual dividend for 2024 was ¥0.04
• Chengdu Olymvax Biopharmaceuticals's trailing twelve-month (TTM) dividend yield is 0.33%
• Chengdu Olymvax Biopharmaceuticals's payout ratio for the trailing twelve months (TTM) is -608.97%

Chengdu Olymvax Biopharmaceuticals Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-06-25¥0.04annually2024-06-25

Chengdu Olymvax Biopharmaceuticals Dividend per year

Chengdu Olymvax Biopharmaceuticals Dividend Yield

Chengdu Olymvax Biopharmaceuticals current trailing twelve-month (TTM) dividend yield is 0.33%. Interested in purchasing Chengdu Olymvax Biopharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Chengdu Olymvax Biopharmaceuticals Financial Ratios

P/E ratio-1050.76
PEG ratio-4.97
P/B ratio5.32
ROE-0.51%
Payout ratio-608.97%
Current ratio1.86
Quick ratio1.67
Cash Ratio0.40

Chengdu Olymvax Biopharmaceuticals Dividend FAQ

Does Chengdu Olymvax Biopharmaceuticals stock pay dividends?
Chengdu Olymvax Biopharmaceuticals does not currently pay dividends to its shareholders.
Has Chengdu Olymvax Biopharmaceuticals ever paid a dividend?
No, Chengdu Olymvax Biopharmaceuticals has no a history of paying dividends to its shareholders. Chengdu Olymvax Biopharmaceuticals is not known for its dividend payments.
Why doesn't Chengdu Olymvax Biopharmaceuticals pay dividends?
There are several potential reasons why Chengdu Olymvax Biopharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Chengdu Olymvax Biopharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Chengdu Olymvax Biopharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Chengdu Olymvax Biopharmaceuticals a dividend aristocrat?
Chengdu Olymvax Biopharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Chengdu Olymvax Biopharmaceuticals a dividend king?
Chengdu Olymvax Biopharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Chengdu Olymvax Biopharmaceuticals a dividend stock?
No, Chengdu Olymvax Biopharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Chengdu Olymvax Biopharmaceuticals stocks?
To buy Chengdu Olymvax Biopharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Chengdu Olymvax Biopharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.